The Board of D2M sits on a number grant panels and has many years of experience in focusing applications towards the needs of a given ‘call’. UMIP and various UMIC Incubator continued…
In April 2010 D2M provided strategic guidance directly to UMIC Ltd prior to a Strategy review Board meeting.
“Myself as Managing Director and our Incubator Manager, Tony Walker, continued…
In June 2009, D2M produced a document for Office for Life Sciences (OLS) relating to the development of life science super clusters within the North West. Focussing on the regional clinical, continued…
Working closely with UMIC ( www.www.umic.co.uk ), one of the Knowledge Providers in the NWDA Innovation Voucher Scheme, D2M (Discovery 2 Medicine, www.discovery2medicine.com ) continued…
Working closely with UMIC ( www.www.umic.co.uk ), one of the Knowledge Providers in the NWDA Innovation Voucher Scheme, D2M (Discovery 2 Medicine, www.discovery2medicine.com ) continued…
D2M has engaged with UMIP ( www.umip.com ) on a project to identify opportunities and issues in addressing unmet clinical needs and securing future commercial value. The highly continued…
The following activity was funded jointly by the NWDA and UMIP.
D2M worked alongside UMIP ( www.umip.com ) on a project to explore the current issues confounding the continued…
Prof. David Ray, at The University of Manchester, carries out pioneering research into glucocorticoid and cytokine actions, sensitivity and interactions in human disease. Prof. Ray was continued…
CoEBio3 contacted D2M for the synthesis of a multifunctional key intermediate vital to facilitate their internal work. This compound was reported to follow a patent route, which in the continued…
An academic at The University of Manchester contacted D2M to carry out computational docking studies with a view to identifying potential peptides to modify cell adhesion. A number of putative continued…
The University of Manchester Intellectual Property Ltd (UMIP) required a comprehensive review to be conducted for one of its clients, for which they approached D2M. This involved carrying out continued…
Dr Curtis Dobson from the Department of Optometry and Neuroscience has discovered some novel lead peptides, based on parts of human proteins, which have exciting anti-viral and anti-infective continued…
Rheumatoid arthritis (RA), the largest potentially modifiable cause of disability in the Western World, is caused by a profound inflammatory response in synovial joints in which neutrophils play a continued…
